China NT Pharma Group Company Limited (HKG:1011)
Hong Kong · Delayed Price · Currency is HKD 0.7400
+0.1400 (23.33%)
Jul 22, 2025, 4:08 PM HKT
HKG:1011 Revenue
In the year 2024, China NT Pharma Group Company had annual revenue of 37.96M CNY with 415.34% growth. China NT Pharma Group Company had revenue of 6.66M in the half year ending December 31, 2024.
Revenue
37.96M CNY
Revenue Growth
-133.55%
P/S Ratio
12.35
Revenue / Employee
1.73M CNY
Employees
22
Market Cap
498.94M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |